Crohn's disease after surgery: Changes in post‐operative management strategies over time and their impact on long‐term re‐operation rate—A retrospective multicentre real‐world study
Alimentary Pharmacology & Therapeutics · 2024
DOI: 10.1111/apt.18001 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Alimentary Pharmacology & Therapeutics, 2024. Verfasst von Annalisa Aratari und 9 weiteren Autor:innen. Beteiligte Einrichtung: IBD Unit, San Filippo Neri Hospital, Rome, Italy. Hauptthemen laut MEDLINE: Crohn Disease, Reoperation. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 46 Literaturangaben.
Abstract (Originalsprache)
Background
Few data are available addressing the impact of post‐operative management of Crohn's disease (CD) on long‐term clinical course.
Aim
To assess the evolution of post‐operative management strategies over the last 40 years and their impact on the re‐operation rate of CD.
Methods
We included 657 patients with CD who had undergone their first radical ileo‐caecal resection between 1980 and 2020. Three cohorts were defined according to year of surgery: cohort 1 (1980–1998; n = 198), cohort 2 (1999–2009; n = 218) and cohort 3 (2010–2020; n = 241). We estimated exposure to immunomodulators and anti‐TNFα agents after surgery and rates of re‐operation using Kaplan–Meier survival analyses. We used Cox proportional hazards regression to assess the association of clinical variables with time to re‐operation.
Results
Immunosuppressants, (IMMs) and anti‐TNFα exposure within 5 years after surgery increased significantly from cohort 1 to cohort 2 and cohort 3 (IMMs: 1.6%, 38.2% and 28.0%, respectively, p < 0.001; anti‐TNFα: 0.0%, 20.7% and 52.0%, respectively, p < 0.001). There was no significant difference across cohorts regarding the cumulative probability of re‐operation within 5 and 10 years. Multivariate analysis identified IMMs/anti‐TNFα exposure before the first surgery (HR 9.15; 95% CI 2.77–30.21) and post‐operatively (HR: 0.24; 95% CI 0.07–0.74) as variables associated with the risk of re‐operation. However, these associations had a time‐varying effect and become non‐significant after 5 and 2 years after surgery, respectively.
Conclusion
Despite increased post‐operative use of IMMs and anti‐TNFα agents in the last two decades, the impact of these strategies on the risk of long‐term re‐operation rate has been modest.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- IBD Unit, San Filippo Neri Hospital, Rome, Italy.
- Gastroenterology Unit, San Camillo-Forlanini Hospital, Rome, Italy.
- IBD Unit, Digestive Disease Center (CEMAD) Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Rome, Italy.
- Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.
- IBD Unit, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.
- Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.
ORCID-Profile: Annalisa Aratari, Maria Lia Scribano, Stefano Festa
Zitieren
APA
Aratari, A., Scribano, M. L., Pugliese, D., Baccolini, V., De Biasio, F., Verna, S., Morretta, C., Festa, S., Armuzzi, A., & Papi, C. (2024). Crohn's disease after surgery: Changes in post‐operative management strategies over time and their impact on long‐term re‐operation rate—A retrospective multicentre real‐world study. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.18001
Vancouver
Aratari A, Scribano ML, Pugliese D, Baccolini V, De Biasio F, Verna S, et al. Crohn's disease after surgery: Changes in post‐operative management strategies over time and their impact on long‐term re‐operation rate—A retrospective multicentre real‐world study. Alimentary Pharmacology & Therapeutics. 2024. doi:10.1111/apt.18001
BibTeX
@article{Aratari2024,
author = {Aratari, Annalisa and Scribano, Maria Lia and Pugliese, Daniela and Baccolini, Valentina and De Biasio, Fabiola and Verna, Serena and Morretta, Chiara and Festa, Stefano and Armuzzi, Alessandro and Papi, Claudio},
title = {Crohn's disease after surgery: Changes in post‐operative management strategies over time and their impact on long‐term re‐operation rate—A retrospective multicentre real‐world study},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2024},
doi = {10.1111/apt.18001}
}
EUVIMED